Diopsys Highlights Educational Initiatives For ESCRS 2018

Diopsys announced educational initiatives for the ESCRS 2018 Congress in Vienna, Austria, September 22-26. In addition to presentations that highlight how the various forms of testing available on Diopsys devices add to the management of eye care patients, the company will also be introducing the concept of Light Induced Visual-Response (LIV) to attendees.

Earlier this year, Diopsys reframed the kind of testing performed on its medical devices. The decision was an acknowledgement that visual electrophysiology testing has a perception within the eye care community that does not reflect the modern protocols and platforms that Diopsys provides. For example, by using patented skin sensors, Diopsys LIV testing is patient friendly, and because of the small physical footprint of Diopsys devices, testing is readily accessible to practicing clinicians.

Additionally, the reports generated by the Diopsys NOVA, ARGOS, and RETINA PLUS devices are intuitive, using documented reference ranges for color-coding. This makes the results of LIV testing highly relevant for making a diagnosis, following patients over time and directing treatment decisions.

“When we heard from eye care physicians that traditional electrophysiology testing might be too complicated and might not be relevant to everyday practice, we sensed a need to clarify what Diopsys platforms add to routine eye care,” Bill Shields, Vice President, International Sales, Diopsys, said in a company news release. “In talking about LIV, we are calling it exactly what it is: a measure of electrical response within the cells along the visual pathway to a light-based stimulus.”

LIV is more than a name change, and instead underscores the value of having an easy-to-use testing modality that provides objective information about the function of the retina. Several booth presentations at the ESCRS Congress will highlight the benefit of LIV testing performed on Diopsys platforms in the routine care of common eye diseases. Presentations will take place in Diopsys booth #C614:

• “Clinical Use of Diopsys ffERG for Managing Retina Patients”
  Andre Romano, Americana, Brazil, Saturday, September 22, 2:30-3:30 PM
• “Integrating Modern Visual Electrophysiology in the Everyday Clinical Practice”
  William Ayliffe, London, UK, Sunday, September 23, 1:30-2:30 PM
• “Structure and Function Analysis with Diopsys pERG for Glaucoma Patients”
  Michel Puech, Paris, France, Monday, September 24, 1:30-2:30 PM

For more info visit http://info.diopsys.com/escrs.